Does PALBOCICLIB Cause Pulmonary oedema? 439 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 439 reports of Pulmonary oedema have been filed in association with PALBOCICLIB (Ibrance). This represents 0.5% of all adverse event reports for PALBOCICLIB.
439
Reports of Pulmonary oedema with PALBOCICLIB
0.5%
of all PALBOCICLIB reports
41
Deaths
230
Hospitalizations
How Dangerous Is Pulmonary oedema From PALBOCICLIB?
Of the 439 reports, 41 (9.3%) resulted in death, 230 (52.4%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Pulmonary oedema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 439 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Pulmonary oedema?
ADALIMUMAB (1,196)
MACITENTAN (1,019)
SACUBITRIL\VALSARTAN (958)
DASATINIB (873)
TREPROSTINIL (866)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (783)
AMLODIPINE (774)
LENALIDOMIDE (706)
FUROSEMIDE (571)
IBRUTINIB (494)
Which PALBOCICLIB Alternatives Have Lower Pulmonary oedema Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID